INFLUENCE OF RATE- AND RHYTHM-CONTROL THERAPY ON THE FREQUENCY OF HOSPITALIZATIONS IN PATIENTS WITH ATRIAL FIBRILLATION

Download full text PDF
Issue: 
3
Year: 
2015

O. Gaisenok, Candidate of Medical Sciences; A. Leonov FSI «United Hospital with Outpatient Department» Managing Affairs of the President of the Russian Federation

Analysis of the frequency of hospitalizations in patients with atrial fibrillation, depending on the choice of rate- or rhythm-control therapy are shown in this article, according to the data of ROC-AF-2013-registry (Registry Of the Cardiology department, 2013).
Keywords: 
atrial fibrillation rhythm-control therapy
rate-control therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Filatov A.G., Tarashvili E.G. Epidemiologija i sotsial'naja znachimost' fibrilljatsii predserdij // Annaly aritmologii. – 2012; 2: 5–13.
  2. Rothberger, C., Winterberg, H. . Vorhofflimmern Und Arrhythmia Perpetua // Wien Klin. Wochenschr. – 1909; 22: 839–44.
  3. Lewis, T. Auricular Fibrillation: a Common Clinical Condition // Br. Med. J. – 1909; 2: 1528.
  4. Shevchenko N.M., Grossu A.A. . Narushenija ritma serdtsa / M.: KONTIMED, 1992; 142 s.
  5. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation // N. Engl. J. Med. – 2002; 347: 1825–33
  6. Camm A., Savelieva I., Lip G. Rate control in the medical management of atrial fibrillation // Heart. – 2007; 93 (1): 35–8.
  7. Ogawa S., Yamashita T., Yamazaki T. et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM study // Circ. J. – 2009; 73: 242–8.
  8. Opolski G., Torbicki A., Kosior D. et al. Rate control vs rhythm control in patients with non-valvular persistent atrial fibrillation: the results of the polish how to treat chronic atrial fibrillation (HOT CAFE) study // Chest. – 2004; 126: 476–86.
  9. Camm A., Kirchhof P., Lip G. et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the european society of cardiology (ESC) // Eur. Heart J. – 2010; 31: 2369–429.
  10. Diagnostika i lechenie fibrilljatsii predserdij. Rekomendatsii RKO, VNOA i ASSH, 2012 g
  11. Gajsenok O.V., Martsevich S.Ju., Kalashnikov S.V. i dr. O roli dupleknogo skanirovanija sonnyh arterij v vyjavlenii korreljatsii mezhdu karotid-nym i koronarnym aterosklerozom po rezul'tatam koronaroangiografii u patsientov s IBS: stabil'noj stenokardiej // Ter. arh. – 2012; 4: 35–8.
  12. Gajsenok O.V., Martsevich S.Ju. Prognosticheskaja znachimost' integral'nyh indeksov v diagnostike ishemicheskoj bolezni serdtsa v zavisimosti ot vozmozhnosti vypolnenija proby s dozirovannoj fizicheskoj nagruzkoj // Kardiologija. – 2013; 5 (8): 24–7.
  13. Gasilin V.S., Dorofeeva E.V., Rozova N.K. Opyt dlitel'nogo primenenija allapinina v poliklinicheskoj praktike // Kardiologija. – 1990; 9: 30–2.
  14. Syrkin A.L., Ivanov G.G., Aksel'rod A.S. i dr. Prognozirovanie effektivnosti antiaritmicheskoj terapii pri paroksizmal'noj forme fibrilljatsii predserdij // Kardiol. i serdechno-sosudistaja hirurgija. – 2010; 4: 84–7.
  15. Junusov V., Nikolaeva I., Plechev V. i dr. Opyt primenenija Allapinina v perioperatsionnom periode koronarnogo shuntirovanija // Vrach. – 2014; 10: 64–71.
  16. Kotljarov A., Karjakina T., Dmitrieva O. Farmakoterapija pri narushenijah ritma // Vrach. – 2014; 12: 12–6
  17. Kanorskiy S. Antiarrhythmic therapy in patients with paroxysmal and persistent atrial fibrillation: prediction and prevention of progression to permanent form of arrhythmia // Intern. J. Heart Vasc. Dis. – 2014; 2 (4): 3–11.
  18. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction // N. Engl. J. Med. – 1992; 327: 227–3.
  19. Epstein E., Hallstrom A., Rogers W. et al. Mortality Following Ventricular Arrhythmia Suppression by Encainide, Flecainide, and Moricizine After Myocardial InfarctionThe Original Design Concept of the Cardiac Arrhythmia Suppression Trial (CAST) // JAMA. – 1993; 270 (20): 2451–5.